Skip to main content
. 2015 Dec 8;27(3):539–543. doi: 10.1093/annonc/mdv598

Table 2.

Frequency of mutations (n = patients)

Mutations detected in >20% of patients Mutations detected in >15% of patients Mutations detected in >10% of patients
TP53 (10), RB1 (6) BCL6 (3), BLM (3), BRCA1 (3), CIC (3), MAP3K1 (3), NF1 (3), POT1 (3), WDR90 (3), WHSC1 (3) APC (2), ARID2 (2), ASXL1 (2), ATRX (2), BRCA2 (2), CCT6B (2), CDK12 (2), CDKN2A (2), CHD2 (2), CHEK2 (2), CIITA (2), CPS1 (2), EP300 (2), EXOSC6 (2), FANCE (2), FRS2 (2), GRIN2A (2), HDAC7 (2), IRS2 (2), JAK1 (2), LRP1B (2), LRRK2 (2), MDM2 (2), MED12 (2), NOTCH1 (2), NTRK1 (2), PIK3R2 (2), RAD50 (2), SDHC (2), TET2 (2)